Global Pharmacovigilance of Aesthetic Botulinum Toxin Type A: Analysis of Adverse Event Reports From the USA , Europe, Canada, and Australia

Key Points

• The research aims to examine the effectiveness and safety reporting of aesthetic Botulinum Toxin Type A.
• Analysis of adverse event reports from the USA, Europe, Canada, and Australia
• Comparison of reporting trends across different regions
• Assessment of the effectiveness issues versus traditional safety concerns
• Effectiveness issues were more predominant than safety concerns in reports
• Notable geographic concentration of reports in the United States
• Indication of systematic underreporting of adverse events internationally

Abstract